Neuca, healthcare

Neuca stock rises 2.04 percent after PLN 499 million fine

Published on 09/24/2026 at 22:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Neuca stock stood 18.32 percent below its PLN 857 52-week high on September 24, 2026. Q2 revenue rose 9.3 percent to PLN 3,570.9 million.

Neuca,  healthcare,  pharmaceutical distribution,  regulatory fine,  Warsaw Stock Exchange, Illustration mit AI erstellt.
Neuca, healthcare, pharmaceutical distribution, regulatory fine, Warsaw Stock Exchange, Illustration mit AI erstellt.

Neuca stock stood at PLN 700 on the Warsaw Stock Exchange on September 24, 2026, up 2.04 percent from the prior close of PLN 686. The move followed a regulatory shock that had pushed the shares sharply lower earlier in the week, according to Reuters.

Fine creates a major risk test

On September 21, 2026, Poland's competition regulator imposed a PLN 499 million fine on Neuca over alleged participation in a drug pricing cartel lasting more than 10 years. Reuters reported that the shares were down 15.6 percent at 10:45 a.m. GMT that day.

Neuca said it disagreed entirely with the charges and planned to appeal to Poland's Court of Competition and Consumer Protection, as Reuters reported. The legal process therefore matters as much as the fine itself for the stock's risk assessment.

Q2 results beat consensus

Neuca's Q2 2026 revenue reached PLN 3,570.9 million, up 9.3 percent from PLN 3,268.0 million a year earlier. The result was 2.2 percent above the PLN 3,493.0 million consensus, according to Bankier.pl.

EBITDA rose 32.3 percent year over year to PLN 98.8 million, beating the PLN 92.0 million consensus by 7.4 percent. Net income attributable to the parent company's shareholders increased 105.6 percent to PLN 40.8 million, compared with PLN 19.8 million in Q2 2025.

Wholesale remains the earnings engine

The wholesale business generated PLN 3,180 million in Q2 2026 revenue, up 8.0 percent year over year, while operating profit in the segment rose 45.8 percent to PLN 38.2 million. Those figures show that operating leverage was visible before the regulatory dispute, according to BiznesRadar.

For the first half of 2026, group sales reached PLN 7,127.8 million, up 7.4 percent from PLN 6,633.9 million in the first half of 2025. The contrast is clear: operating performance improved, while the fine introduced a separate legal and capital risk.

Stock remains below its yearly high

At PLN 700 on September 24, 2026, Neuca traded 18.32 percent below its 52-week high of PLN 857 and 11.64 percent above its 52-week low of PLN 627. Market capitalization stood at PLN 3,165,961,400 on the same date.

Neuca market data and profile

  • Company: Neuca S.A.
  • Ticker: NEU
  • Trading venue: Warsaw Stock Exchange
  • Price as of September 24, 2026: PLN 700
  • Market capitalization: PLN 3,165,961,400 as of September 24, 2026
  • 52-week range: PLN 627-857 as of September 24, 2026
  • Sector / Industry: Healthcare / Medical distribution

Disclaimer...

en | boerse | 70179395 |